ATE478078T1 - Pyridooxazepin-progesteronrezeptor-modulatoren - Google Patents

Pyridooxazepin-progesteronrezeptor-modulatoren

Info

Publication number
ATE478078T1
ATE478078T1 AT07820620T AT07820620T ATE478078T1 AT E478078 T1 ATE478078 T1 AT E478078T1 AT 07820620 T AT07820620 T AT 07820620T AT 07820620 T AT07820620 T AT 07820620T AT E478078 T1 ATE478078 T1 AT E478078T1
Authority
AT
Austria
Prior art keywords
pyridooxazepine
receptor modulators
progesterone receptor
progesterone
modulators
Prior art date
Application number
AT07820620T
Other languages
English (en)
Inventor
Johannes Bernardus Maria Rewinkel
Brigitte Johanna Bernita Folmer
Maria Lourdes Ollero-Ollero
Hemen Ibrahim
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE478078T1 publication Critical patent/ATE478078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07820620T 2006-09-27 2007-09-26 Pyridooxazepin-progesteronrezeptor-modulatoren ATE478078T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121372 2006-09-27
PCT/EP2007/060225 WO2008037746A1 (en) 2006-09-27 2007-09-26 Pyridooxazepine progesteron receptor modulators

Publications (1)

Publication Number Publication Date
ATE478078T1 true ATE478078T1 (de) 2010-09-15

Family

ID=37813577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07820620T ATE478078T1 (de) 2006-09-27 2007-09-26 Pyridooxazepin-progesteronrezeptor-modulatoren

Country Status (27)

Country Link
EP (1) EP2066677B1 (de)
JP (1) JP2010504943A (de)
KR (1) KR20090064454A (de)
CN (1) CN101522689B (de)
AR (1) AR063018A1 (de)
AT (1) ATE478078T1 (de)
AU (1) AU2007302007B2 (de)
BR (1) BRPI0716830A2 (de)
CA (1) CA2664120A1 (de)
CL (1) CL2007002788A1 (de)
CO (1) CO6160325A2 (de)
CY (1) CY1110846T1 (de)
DE (1) DE602007008589D1 (de)
DK (1) DK2066677T3 (de)
ES (1) ES2349325T3 (de)
HR (1) HRP20100526T1 (de)
IL (1) IL197365A0 (de)
MX (1) MX2009002804A (de)
NO (1) NO20091016L (de)
NZ (1) NZ575276A (de)
PE (1) PE20071451A1 (de)
PL (1) PL2066677T3 (de)
PT (1) PT2066677E (de)
RU (1) RU2009115643A (de)
SI (1) SI2066677T1 (de)
TW (1) TW200820975A (de)
WO (1) WO2008037746A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
CN101200429B (zh) * 2006-12-13 2012-08-22 上海睿智化学研究有限公司 2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020526A2 (en) * 2000-09-07 2002-03-14 Bayer Pharmaceuticals Corporation Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators

Also Published As

Publication number Publication date
ES2349325T3 (es) 2010-12-30
HK1126767A1 (en) 2009-09-11
MX2009002804A (es) 2009-03-31
IL197365A0 (en) 2009-12-24
CY1110846T1 (el) 2015-06-10
PT2066677E (pt) 2010-11-10
BRPI0716830A2 (pt) 2013-11-05
HRP20100526T1 (hr) 2010-11-30
NZ575276A (en) 2011-07-29
CN101522689A (zh) 2009-09-02
SI2066677T1 (sl) 2010-12-31
EP2066677A1 (de) 2009-06-10
DK2066677T3 (da) 2010-11-08
RU2009115643A (ru) 2010-11-10
CA2664120A1 (en) 2008-04-03
CN101522689B (zh) 2012-01-11
AU2007302007B2 (en) 2012-02-02
PE20071451A1 (es) 2008-10-30
AR063018A1 (es) 2008-12-23
JP2010504943A (ja) 2010-02-18
WO2008037746A1 (en) 2008-04-03
DE602007008589D1 (de) 2010-09-30
KR20090064454A (ko) 2009-06-18
CL2007002788A1 (es) 2008-04-18
TW200820975A (en) 2008-05-16
CO6160325A2 (es) 2010-05-20
NO20091016L (no) 2009-03-30
PL2066677T3 (pl) 2011-02-28
AU2007302007A1 (en) 2008-04-03
EP2066677B1 (de) 2010-08-18

Similar Documents

Publication Publication Date Title
DK2081951T3 (da) Progesteron-receptorantagonister
DK2297100T3 (da) Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer
DK2262808T3 (da) Chemokinreceptormodulatorer
SMT201400083B (it) Modulatori dei recettori toll-like
BRPI0820447A2 (pt) Agonistas do receptor de glicocorticóides
ATE509022T1 (de) Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
BRPI0810815A2 (pt) Dispositivo de fixação
ATE537157T1 (de) Substituierte phenoxy-n-alkylierte thiazoledindione als östrogenassoziierte rezeptor-alpha-modulatoren
BRPI0813651A2 (pt) Compostos de tiazolopiridina moduladores de sirtuína
BRPI0809511A2 (pt) Dispositivo de distribuição transdérmica de microagulha
DK2013109T3 (da) Forbedret distributionsapparat
EP2009411A4 (de) Kombinations-ausgleichsvorrichtung
GB0701992D0 (en) Grehlin Receptor Modulators
BRPI0822061A2 (pt) Moduladores do receptor canabinoide
DE602007001745D1 (de) Anschlussvorrichtung
DK2066677T3 (da) Pyridooxazepinprogesteronreceptormodulatorer
ZA200800690B (en) Non-steroidal progesterone receptor modulators
DE602006005138D1 (de) Nichtsteroide glucocorticoid-rezeptormodulatoren
ZA200806237B (en) Cannibinoid receptor modulators
GB0622569D0 (en) Cannabinoid receptor modulators
BRPI0920825A2 (pt) modulador seletivo do receptor de estrogênio
DE502007005650D1 (de) Handbremseinrichtung
DE602006020489D1 (de) Cb1-rezeptormodulatoren
ZA200907546B (en) New progesterone receptor modulators
DK1991559T3 (da) Oxasteroidderivater som selektive progesteronreceptormodulatorer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2066677

Country of ref document: EP